About Guerbet
Guerbet is a publicly listed company based in Villepinte (France) founded in 1926. Contrast agents and delivery systems are developed for medical imaging. The company has 2,900 employees. Its website guerbet.com draws about 33 thousand monthly visits. Its Indian entity Guerbet India Private Limited reported revenue of ₹33.96 Cr. Guerbet offers products and services including Dotarem, Elucirem, OptiStar Elite, and OptiVantage. Its focus areas include Life Sciences, Imaging Diagnostics and Contrast Exposure Management.
Company details
Guerbet was founded in 1926 and is headquartered in Villepinte, France. Operations focus on the medical imaging sector, where contrast media and delivery systems are provided for CT scans, Cath Lab procedures, MRI examinations, interventional radiology, and theranostic applications. A range of medical devices is also supplied for angiography, scanners, and MRI setups, supporting diagnostic and therapeutic needs in healthcare settings.
- Headquarters Villepinte, France
- Employees 2,900
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website guerbet.com
- Social LinkedIn X Instagram YouTube
- Legal Name Guerbet Sa
- Indian entity revenue₹33.96 Cr
FY 2025 · +29% YoY
- Indian entity net profit₹31 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹71.6 Lakh
FY 2025 · 2% margin
- Employee Count2,900
Associated legal entities of Guerbet
Guerbet operates through Guerbet India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Guerbet India Private Limited CIN U24100MH2020FTC343504 | Active | 08 Aug 2020 | Mumbai, Maharashtra | ₹34.0 Cr | 25 | 3 | View details |
Products & Services of Guerbet
Guerbet offers a comprehensive portfolio of products and services, including Dotarem, Elucirem, OptiStar Elite, and OptiVantage.
Contrast agent used for enhancing MRI diagnostic imaging
Agent for magnetic resonance imaging procedures
Device for delivering contrast in MRI scans
Multi-use injector for CT contrast administration
Apps and channels of Guerbet
its YouTube channel Guerbet Group has 6.18K subscribers and 30 videos.
Videos from Guerbet
The most watched videos on Guerbet's YouTube channel, Guerbet Group (6.18K subscribers). Click a video to play it here.
More on Guerbet Group.
Board of directors of Guerbet India Private Limited (Guerbet)
Guerbet India Private Limited is the primary company behind Guerbet. The board of Guerbet India Private Limited currently have 3 directors; the longest-serving is Thekkudan Preman Ghosh, appointed in 2021. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Thekkudan Preman Ghosh DIN 09193793 | Director | 10 Jun 2021 | 5 yrs 5 mo | Guerbet India Private Limited |
| Heng Foong Yen DIN 10539107 | Director | 26 Mar 2024 | 2 yrs 7 mo | Guerbet India Private Limited |
| Willem Bjoern Henning Mueller DIN 10539119 | Director | 26 Mar 2024 | 2 yrs 7 mo | Guerbet India Private Limited |
People of Guerbet
171 people are tracked at Guerbet (32 in leadership, 10 in board & advisors, 129 in team); the tracked headcount is 2,900.
| Name | Role | Group |
|---|---|---|
Frantz Hebert | Global Head Of Clinical Development | Leadership |
Guylaine Casses | Global Head Of Regulatory Affairs For Medical Device | Leadership |
Chuck Cook | IT Director | Leadership |
François Nicolas | SVP R&D, R&I & Chief Digital Officer | Leadership |
Jérôme Estampes | CFO & SVP, Business Development & Licensing | Leadership |
Jean-Philippe Lacour | Head Of Global Vigilance Operations - Interventional Imaging | Leadership |
Nadia Hanine | Responsable Qualité CMO | Leadership |
Laurent Londais | CTO Infrastructure & Operations | Leadership |
Solenne Caillibot | Head Of Support Function And R&d/r&i Controlling Group | Leadership |
Luke Poloniecki | Head Of Business Development & Licensing / M&a | Leadership |
Olivier Walch | Group Industrial & Supply Chain Controlling Director | Leadership |
Marc-Michel Rohé | Head Data Science AI | Leadership |
Didier Verot | Global R&d Director | Leadership |
Thomas Luaces | Chief Of Staff To The CCO | Leadership |
Nathalie Fretellier | R&d Manager : Head Of Regulatory Preclinical Department / Researcher In Biology And Toxicology | Leadership |
Sacha Gallet | Head Of Quality Site | Leadership |
Moncef Kafi | Head Regulatory Compliance And Data Management | Leadership |
Camille Pitrou | Head Of Clinical Projects - Pharma | Leadership |
Sarah Catoen | Global Discovery Director | Leadership |
Charbel Saade | Interim Global Director Technical Service Operations | Leadership |
151 more people are available in the full profile.
Complete people profiles for Guerbet
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Guerbet
Guerbet is a publicly listed company on the EURONEXT with ticker symbol GBT in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date19 Jan 1999
- Listed onEuronext: GBT
- Listed entityGuerbet SA
- Exchange sectorHealth technology
- ISINFR0000032526
- Share price6.50 EUR (+3.17% on the day) · 2026-10-14
- Market capitalisation79,402,055.00 EUR
- Price to earnings29.1
- EPS (diluted, trailing year)-11.38 EUR
- Volume (last session)22,019
Financials of Guerbet
Figures of Guerbet India Private Limited, the primary company behind Guerbet, for FY 2025. Revenue was ₹33.96 Cr (+29% year on year). Net profit was ₹31 Lakh (1% margin). EBITDA was ₹71.6 Lakh (2% margin). Revenue has grown at a compounded annual rate of +42% over three years.
- ₹33.96 CrRevenue · FY 2025 · +29% YoY
- ₹31 LakhNet profit · 1% margin
- ₹71.6 LakhEBITDA · 2% margin
- ₹83 LakhPaid-up capital
- 25Employees (provident fund records)
- +42%Revenue CAGR, 3 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 786.4M EUR | -108.3M EUR | 62.2M EUR |
| 2024 | 841.1M EUR | 16.1M EUR | 104.1M EUR |
| 2023 | 785.7M EUR | 23.9M EUR | 93.6M EUR |
| 2022 | 753.3M EUR | -41.1M EUR | 91.2M EUR |
| 2021 | 732.1M EUR | 32.6M EUR | 92.7M EUR |
Balance sheet, profit and loss, cash flow and ratios of Guerbet India Private Limited are on its company page.
Detailed financial statements for Guerbet
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Guerbet
The website of Guerbet (guerbet.com) receives about 32.6K visits a month and ranks #864,402 among all websites worldwide, #1,043 in Biotechnology and Pharmaceuticals.
- Monthly visits32.6K
▼ 12.6% vs previous month
- Unique visitors16.2K
per month
- Global rank#864,402
among all websites
- Category rank#1,043
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.7
- Average visit34 sec
- DevicesDesktop 43% · Mobile 57%
Websites whose visitors overlap most with Guerbet. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| vrtx.com | 100% | 342.2K | #151,023 | View details | |
fspf.fr | fspf.fr | 70% | #2,424,613 | – | |
cardiovascularbusiness.com | cardiovascularbusiness.com | 66% | #301,603 | – | |
dimag.com | dimag.com | 65% | – | ||
sinjune.com | sinjune.com | 64% | #8,681,865 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Guerbet
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Guerbet
Complete news archive for Guerbet
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Guerbet
Guerbet was founded in 1926.
Guerbet is headquartered in Villepinte, France. It is registered at Villepinte, Ile-de-france, France.
Guerbet has 2,900 employees.
The primary company behind Guerbet, Guerbet India Private Limited, reported revenue of ₹33.96 Cr for FY 2025, up 29% year on year.
Guerbet was founded in 1926 and is headquartered in Villepinte, France. Operations focus on the medical imaging sector, where contrast media and delivery systems are provided for CT scans, Cath Lab procedures, MRI examinations, interventional radiology, and theranostic applications. A range of medical devices is also supplied for angiography, scanners, and MRI setups, supporting diagnostic and therapeutic needs in healthcare settings.
Guerbet offers Dotarem, Elucirem, OptiStar Elite, and OptiVantage.
Yes, Guerbet is publicly traded on EURONEXT under the ticker symbol GBT.
Guerbet operates through Guerbet India Private Limited.
The legal entities of Guerbet currently have 3 directors, including Heng Foong Yen, Willem Bjoern Henning Mueller, Thekkudan Preman Ghosh.